Publicaciones en las que colabora con Carmen Guadalupe Rodríguez González (6)

2022

  1. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 4, pp. 444-446

  2. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

    International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162

2013

  1. Nuevos tratamientos para la esclerosis múltiple

    Medicina Clinica, Vol. 140, Núm. 2, pp. 76-82